C-Suite Summit logo

Transitioning to the ‘Next Normal’: Biopharma’s Role in Addressing the COVID-19 Crisis and What’s Next

With insights from McKinsey & Company

Now Virtual! Kicking Off With an In-Person Reception on October 14!

In-Person Networking Reception
Thursday, October, 14, 2021 • 4:00 p.m.-6:00 p.m.
Basking Ridge Country Club 185 Madisonville Road, Basking Ridge, NJ 07920
Virtual All-Day Education Program
Friday, October, 15, 2021 • 8:30 a.m.-2:15 p.m.

After closely monitoring updates from the Centers for Disease Control and Prevention and State and local health agencies, as well as speaking with leading epidemiologists, BioNJ has decided to present this year’s full-day C-Suite Summit virtually, instead of its originally planned in-person format.


Transitioning to the “Next Normal” has brought massive disruption to our local and global communities. However, the life sciences industry has met these unprecedented challenges head-on by delivering innovation at an accelerated pace. As we look ahead to our “Next Normal”, join BioNJ and industry experts virtually on Friday, October 15, for BioNJ’s C-Suite Summit, to reflect on this past year’s successes and challenges, discuss the next wave of innovation across the value chain, and to share thoughts on how the industry might deepen and scale its commitment to delivering a positive impact for society.

To kick off BioNJ’s Ninth Annual C-Suite Summit, please join us the evening of Thursday, October 14, 2021, for an in-person Networking Reception. Following safety guidelines, including on-site proof of vaccination and recommended masking, attendees will enjoy networking, cocktails, dinner and first-hand views of the beautifully manicured fairways of the Club’s golf course and 260 private acres.

Take look at this action-packed agenda:

Thursday, October 14, 2021
4:00 p.m.-6:00 p.m.
Networking Reception at the Basking Ridge Country Club
Friday, October 15, 2021 • VIRTUAL

8:30 a.m. – 8:40 a.m.

Welcome & Opening Remarks
Debbie Hart, President & CEO, BioNJ


8:40 a.m. – 9:25 a.m.

Keynote: An Imperative to Lead
Presented by McKinsey & Company

Biopharma rose to the COVID-19 challenge, delivering significant impact for society. The industry is now at an inflection point, with expectations of the industry higher than ever. We’ll discuss the most pressing themes and opportunities that lie on the horizon – including how companies can lead in the context of a mounting Environment, Social, and Governance imperative.

9:25 a.m. – 10:10 a.m.

Panel: Striding into a “New Normal”
Industry leaders will share their reflections on the pandemic and the industry’s impact, what the “Next Normal” holds, and how their companies are advancing an ESG agenda.

Elliott Levy, M.D., Head, Intrepid Alliance; former Senior Vice President, Global Development, Amgen
Brent Ragans, President, Ferring Pharmaceuticals, US
Geralyn Ritter, Executive Vice President, External Affairs & ESG, Organon

Moderator: Lucy Perez, Ph.D., Senior Partner, McKinsey & Company

10:10 a.m. – 10:40 a.m.

Fireside Chat: A Rapidly Evolving Regulatory Landscape
Regulatory experts will share perspectives on emerging trends including the learnings from the “natural experiments” that took place during the pandemic, and what it means for the future of innovation and partnership between pharma and regulatory agencies with a special focus on pricing and policy reform.

Featuring Conversationalists:
Peter Marks M.D., Ph.D., Director, Center for Biologics Evaluation and Research, Food & Drug Administration
Jacqueline Berman, Partner, Morgan Lewis

10:40 a.m. – 10:45 a.m. Break

10:45 a.m. – 11:15 a.m.

Fireside Chat: Digital Patient and HCP Engagement in a Post-COVID World
COVID-19 introduced significant new burdens onto patients and providers, requiring Pharmacos to place heightened emphasis on innovative engagement and experience drivers. Join us to discuss how patient needs and care have evolved, how go-to-market models have shifted, and the role digital engagement strategies will play in responding to this changing landscape – from virtual care delivery to remote physician engagement.

Featuring Conversationalists:
Tamara Elias, M.D.,
Vice President, Global Partnerships & Innovation, MSD, Merck & Co.
Innes Meldrum, Senior Vice President, Chief Commercial Officer, Otsuka
Ben Hohn, Principal, Business Development, Pipeline & Launch Strategy & Emerging Pharma; Lead, ZS Associates

11:15 a.m. – 12:00 p.m.

Panel: Value Creation in the Industry
Biopharma has proven resilient through a challenging year, with innovation continuing to be funded and developed. Experts will share perspectives on the rapidly changing M&A / BD landscape and trends in capital allocation and access.

Steve Bryant, Ph.D.
, Vice President, Head of Global Business Development, Genmab

Daniel Karp, Senior Vice President, Head of Business Development, Organon
Elizabeth Naldi-Jacob, Head of Oncology Business Development for Corporate
Development & GHH, Merck

Moderator: Arda Ural, Ph.D., Americas Industry Market Leader – HS&W | Life Sciences & Healthcare, Ernst & Young LLP

12:00 p.m. – 12:05 p.m. Break

12:05 p.m. – 12:50 p.m.

Panel: Rethinking Resilience – The Global Supply Chain
The supply chain took on new significance in the pandemic demonstrating just how important its vitality is. Experts will discuss recent learnings, what the hallmarks of resilience will look like, and how companies can plan for the unexpected.

Gerry Collins, Global Platform Leader Parenterals, Janssen, Pharmaceutical Companies of Johnson and Johnson
Fred Lowery, Senior Vice President, Thermo Fisher & President, Customer Channels, Thermo Fisher Scientific
Stefan Roehr, Head North America Supply Chain, Distribution, and Logistics, Sanofi

Joseph Goldberg, Director, Strategy & Management Consulting, National Life Sciences Industry Consulting Leader, RSM US LLP

12:50 p.m. – 1:20 p.m.

Fireside Chat: Winning in the Digital Age
Digitization is impacting the world in critical and meaningful ways. Our speaker wrote the book on how to win in the new Digital Age. Nitin Seth will discuss the 7 building blocks of a successful digital transformation and how it pertains to the life sciences in a post-COVID World.

Featuring Conversationalist
Nitin Seth, CEO, Incedo, Inc.

1:20 p.m. – 2:05 p.m.

Fireside Chat: The 5 Mindsets of Inspired Leadership: The Pfizer Story
The supply chain has been forever disrupted with COVID-19. Our speaker led the charge for Pfizer, a major disruptor in the COVID-19 fight…to literally save the world. Michael Ku will share his journey and what it took the Pfizer Team to change the world forever.

Featuring Conversationalist:
Michael Ku, PharmD
, Vice President, Global Clinical Supply, Pfizer

2:05 p.m. – 2:15 p.m.

Closing Remarks
Debbie Hart
, President & CEO, BioNJ

Now a lower cost: Registration is $350 for Members and $450 for future BioNJ Members. The registration fee includes the Networking Reception on Thursday, October 14, 2021, as well as the full-day virtual event on Friday, October 15, 2021. The C-Suite Summit is closed to media. Contact Kim Minton at KMinton@BioNJ.org to learn about Sponsorship opportunities.



Thank You To Our Sponsors